Pricing Log in Create free account

BioLineRx Ltd. (BLRX) vs Curanex Pharmaceuticals Inc (CURX)

BioLineRx Ltd. and Curanex Pharmaceuticals Inc are both Biotechnology companies. BioLineRx Ltd. and Curanex Pharmaceuticals Inc are of similar size ($9.1M and $8.8M). Curanex Pharmaceuticals Inc has the higher net margin (0.00% vs −502.1%) and the lower return on invested capital (−356.7% vs −74.3%). Across the 13 metrics below, BioLineRx Ltd. leads on 7 and Curanex Pharmaceuticals Inc on 6.

Valuation

Metric BLRX CURX Biotechnology median
P/E n/m n/m 10.26
P/S 5.65 n/m 9.18
P/B 0.47 1.71 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 1.06 n/m 8.98
Earnings yield (90.47%) (134.95%) (34.89%)
Free cash flow yield (137.86%) (147.35%) (24.52%)

Profitability

Metric BLRX CURX Biotechnology median
Gross margin 80.03% — 65.16%
Operating margin (874.28%) 0.00% 0.00%
Net margin (502.08%) 0.00% 0.00%
Free cash flow margin (776.29%) 0.00% 0.00%
Return on equity (38.10%) (411.10%) (50.12%)
Return on assets (18.21%) (357.22%) (45.60%)
Return on invested capital (74.28%) (356.67%) 0.00%

Growth

Metric BLRX CURX Biotechnology median
Revenue growth (TTM) (91.93%) — 6.26%
EPS growth (last fiscal year) 93.72% (523.51%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BLRX CURX Biotechnology median
Debt to equity 0.40 0.00 0.00
Current ratio 1.20 45.95 4.89
Net debt to EBITDA 1.22 1.20 1.01

Dividend

Metric BLRX CURX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BLRX CURX Biotechnology median
Market cap 8.80m 9.07m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack